DIABETIC KIDNEY DISEASE
Clinical trials for DIABETIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new DIABETIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for DIABETIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested to boost blood health in diabetic kidney patients
Disease control CompletedThis study tested whether the drug Roxadustat could improve anemia (low red blood cells) in adults with moderate diabetic kidney disease. 124 participants took the drug for 24 weeks while researchers measured changes in their blood health and other factors. The goal was to see if…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE4 • Sponsor: Second Xiangya Hospital of Central South University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Surgery tested to halt diabetes damage in youth
Disease control CompletedThis study looked at whether weight-loss surgery (vertical sleeve gastrectomy) could improve the health of the pancreas, kidneys, and heart in teens and young adults with type 2 diabetes. Researchers enrolled 24 young people, aged 12-21, who were scheduled for this surgery. They …
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE1, PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Gut bacteria battle: can probiotics slow kidney damage in diabetes?
Disease control CompletedThis study tested whether a specific blend of probiotic bacteria could help control diabetic kidney disease. Fifty adults with type 2 diabetes and early-stage kidney problems took the probiotic powder for six months. Researchers measured changes in kidney function, blood sugar, a…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: NA • Sponsor: GenMont Biotech Incorporation • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug shows promise in slowing kidney damage
Disease control CompletedThis study tested a new drug called QRX-3 in people with moderate to advanced chronic kidney disease. Over 12 months, researchers compared whether the drug could slow the decline in kidney function compared to patients who did not receive it. The goal was to see if protecting kid…
Matched conditions: DIABETIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC